FYMRALIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 31 Jul 2023)
What this means for you
This application is over — abandoned 31 Jul 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97458017
- Mark type
- Stylized text
- Filed
- 14 Jun 2022
- Published for opposition
- 01 Nov 2022
- Abandoned
- 31 Jul 2023
- Attorney of record
- Francis J. Duffin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders
Owner
- Tonix Pharmaceuticals, Inc., New York, NY, US
- Tonix Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 31 Jul 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 31 Jul 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Dec 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Nov 2022 — PUBLISHED FOR OPPOSITION
- 12 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Sept 2022 — ASSIGNED TO EXAMINER
- 28 Jun 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Jun 2022 — NEW APPLICATION ENTERED